Patrick Aro

1.4k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Patrick Aro is a scholar working on Neurology, Neurology and Molecular Biology. According to data from OpenAlex, Patrick Aro has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 5 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Patrick Aro's work include Parkinson's Disease Mechanisms and Treatments (11 papers), Alzheimer's disease research and treatments (4 papers) and Neurological disorders and treatments (4 papers). Patrick Aro is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), Alzheimer's disease research and treatments (4 papers) and Neurological disorders and treatments (4 papers). Patrick Aro collaborates with scholars based in United States, China and Norway. Patrick Aro's co-authors include Min Shi, Jing Zhang, Elaine R. Peskind, Cyrus P. Zabetian, Joseph F. Quinn, Carmen Ginghină, Douglas Galasko, William A. Banks, Travis J. Cook and Kristin M. Bullock and has published in prestigious journals such as Neurology, Acta Neuropathologica and Neurobiology of Aging.

In The Last Decade

Patrick Aro

14 papers receiving 1.1k citations

Hit Papers

Plasma exosomal α-synuclein is likely CNS-derived and inc... 2014 2026 2018 2022 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Aro United States 14 605 406 246 245 223 14 1.1k
Travis J. Cook United States 7 511 0.8× 343 0.8× 213 0.9× 134 0.5× 194 0.9× 8 871
WonHee Kim United States 8 698 1.2× 131 0.3× 287 1.2× 569 2.3× 207 0.9× 9 1.1k
Sudad Saman United States 3 621 1.0× 96 0.2× 215 0.9× 361 1.5× 226 1.0× 3 868
Harutsugu Tatebe Japan 17 357 0.6× 378 0.9× 170 0.7× 414 1.7× 53 0.2× 33 1.0k
Edoardo Bistaffa Italy 14 437 0.7× 246 0.6× 215 0.9× 248 1.0× 64 0.3× 27 730
Wolfgang Ruf Germany 11 611 1.0× 873 2.2× 451 1.8× 415 1.7× 121 0.5× 26 1.5k
Katerina Melachroinou Greece 9 581 1.0× 581 1.4× 226 0.9× 305 1.2× 159 0.7× 13 1.1k
Senthilvelrajan Kaniyappan Germany 12 531 0.9× 94 0.2× 202 0.8× 507 2.1× 84 0.4× 17 939
Garth F. Hall United States 20 962 1.6× 255 0.6× 407 1.7× 880 3.6× 242 1.1× 34 1.8k
Lifu Sheng China 11 377 0.6× 170 0.4× 146 0.6× 111 0.5× 122 0.5× 11 635

Countries citing papers authored by Patrick Aro

Since Specialization
Citations

This map shows the geographic impact of Patrick Aro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Aro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Aro more than expected).

Fields of papers citing papers by Patrick Aro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Aro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Aro. The network helps show where Patrick Aro may publish in the future.

Co-authorship network of co-authors of Patrick Aro

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Aro. A scholar is included among the top collaborators of Patrick Aro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Aro. Patrick Aro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Tian, Chen, Tessandra Stewart, Zhen Hong, et al.. (2022). Blood extracellular vesicles carrying synaptic function‐ and brain‐related proteins as potential biomarkers for Alzheimer's disease. Alzheimer s & Dementia. 19(3). 909–923. 52 indexed citations
2.
Hong, Zhen, Chen Tian, Tessandra Stewart, et al.. (2021). Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein–Containing Extracellular Vesicles. Neurology. 96(18). e2332–e2345. 21 indexed citations
3.
Sheng, Lifu, Tessandra Stewart, Patrick Aro, et al.. (2020). Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis. Acta Neuropathologica Communications. 8(1). 102–102. 42 indexed citations
4.
Stewart, Tessandra, Min Shi, Aanchal Mehrotra, et al.. (2019). Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers. Journal of Alzheimer s Disease. 69(1). 263–276. 14 indexed citations
5.
Wang, Hua, Anzari Atik, Tessandra Stewart, et al.. (2018). Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study. Neurobiology of Disease. 116. 53–59. 30 indexed citations
6.
Wang, Hua, Tessandra Stewart, Jon B. Toledo, et al.. (2018). A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer’s Disease and Mild Cognitive Impairment. Journal of Alzheimer s Disease. 61(4). 1541–1553. 33 indexed citations
7.
Shi, Min, Lu Tang, Jon B. Toledo, et al.. (2018). Cerebrospinal fluid α‐synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimer s & Dementia. 14(8). 1052–1062. 38 indexed citations
8.
Li, Yang, Tessandra Stewart, Min Shi, et al.. (2017). An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression. PROTEOMICS - CLINICAL APPLICATIONS. 11(7-8). 13 indexed citations
9.
Pottiez, Gwënaël, Yang Li, Tessandra Stewart, et al.. (2017). Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1–42 in CSF for the Diagnosis of Alzheimer’s Disease. Journal of Proteome Research. 16(3). 1228–1238. 27 indexed citations
10.
Shi, Min, Andrej Kováč, Ané Korff, et al.. (2016). CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease. Alzheimer s & Dementia. 12(11). 1125–1131. 170 indexed citations
11.
Shi, Min, Romel Dator, Patrick Aro, et al.. (2015). Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation*. Molecular & Cellular Proteomics. 14(3). 544–555. 53 indexed citations
12.
Lin, Xiangmin, Min Shi, J. Gunasingh Masilamoni, et al.. (2015). Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1854(7). 779–787. 24 indexed citations
13.
Shi, Min, Changqin Liu, Travis J. Cook, et al.. (2014). Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathologica. 128(5). 639–650. 522 indexed citations breakdown →
14.
Stewart, Tessandra, Luis F. Gonzalez‐Cuyar, David T. Wong, et al.. (2013). Cheek cell–derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control. Neurobiology of Aging. 35(2). 418–420. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026